BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36191254)

  • 1. The Biological Role of Pleural Fluid PAI-1 and Sonographic Septations in Pleural Infection: Analysis of a Prospectively Collected Clinical Outcome Study.
    Bedawi EO; Kanellakis NI; Corcoran JP; Zhao Y; Hassan M; Asciak R; Mercer RM; Sundaralingam A; Addala DN; Miller RF; Dong T; Condliffe AM; Rahman NM
    Am J Respir Crit Care Med; 2023 Mar; 207(6):731-739. PubMed ID: 36191254
    [No Abstract]   [Full Text] [Related]  

  • 2. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokines, fibrinolytic system enzymes, and biochemical indices in children with infectious para-pneumonic effusions.
    Chiu CY; Wong KS; Huang JL; Tasi MH; Lin TY; Hsieh SY
    Pediatr Infect Dis J; 2008 Aug; 27(8):699-703. PubMed ID: 18664985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic and inflammatory processes in pleural effusions.
    Philip-Joët F; Alessi MC; Philip-Joët C; Aillaud M; Barriere JR; Arnaud A; Juhan-Vague I
    Eur Respir J; 1995 Aug; 8(8):1352-6. PubMed ID: 7489803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasminogen Degradation by Neutrophil Elastase in Pleural Infection, Not High Plasminogen Activator Inhibitor-1 (PAI-1), is the Cause of Intrapleural Lytic Failure.
    Barrett CD; Moore PK; Moore EE; Moore HB; Chandler JG; Siddiqui H; Maginot ER; Sauaia A; Pérez-Calatayud AA; Buesing K; Wang J; Davila-Chapa C; Hershberger D; Douglas I; Pieracci FM; Yaffe MB
    Chest; 2024 May; ():. PubMed ID: 38710463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active α-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids.
    Komissarov AA; Florova G; Azghani A; Karandashova S; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2013 Nov; 305(10):L682-92. PubMed ID: 23997178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.
    Komissarov AA; Mazar AP; Koenig K; Kurdowska AK; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2009 Oct; 297(4):L568-77. PubMed ID: 19666776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
    Hua CC; Chang LC; Chen YC; Chang SC
    Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated thoracenteses affect proinflammatory cytokines, vascular endothelial growth factor, and fibrinolytic activity in pleural transudates.
    Chung CL; Yeh CY; Sheu JR; Chen YC; Chang SC
    Am J Med Sci; 2007 Dec; 334(6):452-7. PubMed ID: 18091367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
    Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions.
    Chung CL; Hsiao SH; Hsiao G; Sheu JR; Chen WL; Chang SC
    PLoS One; 2013; 8(1):e53169. PubMed ID: 23308155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
    Kanellakis NI; Wrightson JM; Hallifax R; Bedawi EO; Mercer R; Hassan M; Asciak R; Hedley E; Dobson M; Dong T; Psallidas I; Rahman NM
    BMJ Open Respir Res; 2019; 6(1):e000440. PubMed ID: 31673364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Ratio a Marker of Sonographic Septations in Pleural Infection?
    Yasuma T; D'Alessandro-Gabazza CN; Kobayashi T; Gabazza EC; Fujimoto H
    Am J Respir Crit Care Med; 2023 Apr; 207(7):949. PubMed ID: 36413774
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of intrapleural pingyangmycin administration on activity of fibrinolytic system and transforming growth factor-beta1 in malignant pleural effusion].
    Zhu QQ; Sun GY
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Sep; 32(9):674-8. PubMed ID: 20079281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
    Iakhiaev AV; Nalian A; Koenig K; Idell S
    Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury.
    Tucker T; Idell S
    Semin Thromb Hemost; 2013 Jun; 39(4):373-81. PubMed ID: 23504608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.
    Tucker TA; Jeffers A; Alvarez A; Owens S; Koenig K; Quaid B; Komissarov AA; Florova G; Kothari H; Pendurthi U; Mohan Rao LV; Idell S
    Am J Respir Cell Mol Biol; 2014 Feb; 50(2):316-27. PubMed ID: 24024554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
    Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
    Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting plasminogen activator inhibitor-1 in tetracycline-induced pleural injury in rabbits.
    Florova G; Azghani AO; Karandashova S; Schaefer C; Yarovoi SV; Declerck PJ; Cines DB; Idell S; Komissarov AA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jan; 314(1):L54-L68. PubMed ID: 28860148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema.
    Altmann ES; Crossingham I; Wilson S; Davies HR
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.